Showing results (71-80 of 134) with videos related to
Sort By:
Pageof 14
The European Journal of Neuroscience|August 13, 2004
TNF-alpha accounts for short-term persistence of oxidative status in rat brain after two weeks of repeated stressCarolina Munhoz, José L M Madrigal, Borja García-Bueno, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 22, 2005
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanismsMarta P Pereira, Olivia Hurtado, Antonio Cárdenas, et al.European Journal of Medicinal Chemistry|July 24, 2015
Preliminary research on 1-(4-bromo-2-nitroimidazol-1-yl)-3-[(18)F]fluoropropan-2-ol as a novel brain hypoxia PET tracer in a rodent model of strokeElena Nieto, Mercedes Delgado, Mónica Sobrado, et al.Journal of Neurochemistry|April 23, 2013
Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental strokeOlivia Hurtado, Macarena Hernández-Jiménez, Juan G Zarruk, et al.Annals of Neurology|October 27, 2011
Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosisMarta F Bustamante, Nicolás Fissolo, Jordi Río, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 23, 2003
Inhibition of glutamate release by delaying ATP fall accounts for neuroprotective effects of antioxidants in experimental strokeOlivia Hurtado, Javier De Cristóbal, Verónica Sánchez, et al.Journal of Neuropathology and Experimental Neurology|September 6, 2005
The nonthiazolidinedione PPARgamma agonist L-796,449 is neuroprotective in experimental strokeMarta P Pereira, Olivia Hurtado, Antonio Cárdenas, et al.Molecular Neurobiology|January 5, 2022
Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA AdministrationCarme Gubern-Mérida, Pau Comajoan, Gemma Huguet, et al.British Journal of Pharmacology|June 7, 2023
Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?Alicia García-Culebras, María Isabel Cuartero, Carolina Peña-Martínez, et al.Brain, Behavior, and Immunity|November 19, 2016
Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemiaJesus M Pradillo, Katie N Murray, Graham A Coutts, et al.Pageof 14